CUSIP: 65481J109
Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,134,560
-
Share change
-
+12,134,560
-
Total reported value
-
$183,183,000
-
Price per share
-
$15.15
-
Number of holders
-
42
-
Value change
-
+$183,183,004
-
Number of buys
-
42
Quarterly Holders Quick Answers
What is CUSIP 65481J109?
CUSIP 65481J109 identifies NVLS - NIVALIS THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 65481J109:
Institutional Holders of NIVALIS THERAPEUTICS INC - COM (NVLS) as of Q2 2015
As of 30 Jun 2015,
NIVALIS THERAPEUTICS INC - COM (NVLS) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,134,560 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, Rock Springs Capital Management LP, SABBY MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, FRANKLIN RESOURCES INC, KINGDON CAPITAL MANAGEMENT, L.L.C., and MARSICO CAPITAL MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.